Login / Signup

Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.

Lori B DanielsJunting RenKris KumarQuan M BuiJing ZhangXinlian ZhangMariem A SawanHoward EisenChristopher A LonghurstKaren Messer
Published in: PloS one (2021)
Patients taking statins prior to hospitalization for COVID-19 had substantially lower odds of death, primarily among individuals with a history of CVD and/or hypertension. These observations support the continuation and aggressive initiation of statin and anti-hypertensive therapies among patients at risk for COVID-19, if these treatments are indicated based upon underlying medical conditions.
Keyphrases